Spectrum Pharmaceuticals Shifts From Generics to Its Own Drugs

From: Orange County Business Journal | Date: April 17, 2006| Author: Reed, Vita | Copyright information

Irvine's Spectrum Pharmaceuticals Inc. is looking to make a name for itself.

The company has made moves to jump from generic versions of common drugs to brand-name treatments for cancer.

For now, Spectrum is leaning on its generic sales to fund a push into new drugs. The company sells its own version of GlaxoSmithKline PLC's Imitrex for migraines and Bayer AG's antibiotic Cipro.

"We will keep on benefiting from generic business, but going forward, we will be focusing on b...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

Drug Maker Hits Snag in Bid for Key Product
Orange County Business Journal ; ... shift to brand-name drugs Irvine drug maker Spectrum Pharmaceuticals Inc.'s bid to start selling its first brand-name cancer ... disappointment for Spectrum. The news sent Spectrum's shares down 30% on ... Investors also hammered Spectrum's German development ... Orplatna, ...